This was of particular importance considering that ELF5 not only acts as a tumor suppressor by inhibiting the transcription of ER, MYC and Slug in breast cancer but also acts as a carcinogenic factor in basal-like breast cancer cells and endocrine-resistant cells. Here, ESR1 is linked to neoplasm.